Transgenic models of T-cell prolymphocytic leukaemia.
Stern
M H
MH
Unité INSERM U462, Hôpital Saint Louis, Paris, France. mh.stern@chu-stlouis.fr
D017668:Age of Onset; D000368:Aged; D000375:Aging; D000818:Animals; D018801:CD2 Antigens / Q000235:genetics; D002883:Chromosomes, Human, Pair 14 / Q000235:genetics / Q000648:ultrastructure; D004195:Disease Models, Animal; D015973:Gene Expression Regulation, Leukemic; D006801:Humans; D015463:Leukemia, Prolymphocytic / Q000453:epidemiology / Q000235:genetics*; D015458:Leukemia, T-Cell / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic; D009857:Oncogenes; D011518:Proto-Oncogene Proteins / Q000235:genetics; D012045:Regulatory Sequences, Nucleic Acid; D019076:Transgenes; D014178:Translocation, Genetic / Q000235:genetics; D014960:X Chromosome / Q000235:genetics / Q000648:ultrastructure
D018801:CD2 Antigens; C082870:MTCP1 protein, human; D011518:Proto-Oncogene Proteins